ElectroCore, Inc. Announces Peter Cuneo as Board Chairman, Effective October 1, 2021
September 20, 2021 at 08:00 am EDT
Share
electroCore, Inc. announced that the Board of Directors has appointed Peter Cuneo as Chairman of the Board of Directors, effective October 1, 2021. Mr. Cuneo was appointed to the Board of Directors in April 2020. He succeeds Mike Atieh, who served as Chairman since April 2020 and who will remain on the Board as an independent director and member of the audit committee. Mr. Cuneo currently serves as Non-Executive Chairman of Arrival Group, and serves as Chairman and Chief Executive Officer of CIIC Capital Partners II, which raised approximately $287.5 million in it is initial public offering earlier this month.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Companyâs product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Companyâs TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.